Building Roblox’s $30 Billion Biz; Antibody Treatments with Dr. Scott Gottlieb
Eli Lilly says its Covid-19 antibody therapy reduced the risk of hospitalization and death by 87% in a study of more than 750 high-risk coronavirus patients. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, discusses the news from Lilly and the difficulties around distributing Covid antibody drugs. Kids online gaming company Roblox (RBLX) is going public today through a direct listing on the New York Stock Exchange. Roblox CEO, David Baszucki, discusses the listing, user growth, the path to profitability and why Roblox is so unique. Plus, Tesla’s on a wild ride and inflation has captured investor focus.
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Eli Lilly says its Covid-19 antibody therapy reduced the risk of hospitalization and death by 87% in a study of more than 750 high-risk coronavirus patients. Dr. Scott Gottlieb, member of the boards of Pfizer and biotech company Illumina and former FDA commissioner, discusses the news from Lilly and the difficulties around distributing Covid antibody drugs. Kids online gaming company Roblox (RBLX) is going public today through a direct listing on the New York Stock Exchange. Roblox CEO, David Baszucki, discusses the listing, user growth, the path to profitability and why Roblox is so unique. Plus, Tesla’s on a wild ride and inflation has captured investor focus.
Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.